Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Opsismodysplasia is a skeletal dysplasia characterized by congenital dwarfism and facial dysmorphism.
Features include always present findings: Delayed epiphyseal ossification, Severe short stature, Severe platyspondyly, and Short foot and others; and very common findings: Renal phosphate wasting, Proptosis, Hypophosphatemia, and Shallow orbits and others. 65 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 8 | Squared iliac bones, Hypoplastic pubic bone, Hypoplastic vertebral bodies |
INPPL1 encodes inositol polyphosphate phosphatase like 1 (1,258 aa). Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Highest expression in Cervix Endocervix (132.9 TPM) and Colon Sigmoid (132.0 TPM).
Opsismodysplasia is associated with mutations in the INPPL1 gene on chromosome 11.
The INPPL1 protein participates in PIK3R1:PIK3CA,B,D (PI3K), PLCG2 (PLCgamma2), SHC1 (SHC), PTPN11 (SHP2), GRB2:GAB2, GRB2:GAB3, GRAP2 (MONA), CBL:GRB2, INPP5D (SHIP1), INPPL1 (SHIP2) bind PolyUb,p-8Y-CSF1R and are activated pathway.
INPPL1 is classified as a druggable target (Druggable Genome, Enzyme, and Kinase categories) with score 3.2.
INPPL1-related opsismodysplasia should be suspected in a proband with the following clinical, laboratory, and imaging findings and family history.
Clinical findings
Prenatal-onset disproportionate short stature with short limbs
Characteristic facial features (relative macrocephaly, prominent forehead, midface retrusion, depressed nasal bridge, short nose, anteverted nares, and a relatively long philtrum)
No approved treatments are currently available for opsismodysplasia. The disease remains an area of unmet medical need.
No clinical practice guidelines have been published for INPPL1-related opsismodysplasia. Recommended initial evaluations, treatment, and surveillance are adapted from case reports and best practice guidelines for skeletal dysplasia management [, , , , , , ]. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with INPPL1-related opsismodysplasia, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. INPPL1-Related Opsismodysplasia: Recommended Evaluations Following Initial Diagnosis
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. INPPL1-Related Opsismodysplasia: Recommended Surveillance
No clinical trials have been registered for opsismodysplasia.
6 publications have been identified in PubMed for opsismodysplasia. Research spans Basic Science / Preclinical (50%), Review / Meta-Analysis (17%), and Case Report / Case Series (17%).
Tabanli G (2026). [PMID: 40620719](https://pubmed.ncbi.nlm.nih.gov/40620719/). *Molecular syndromology*. [Clinical Trial Publication]
Voigt B (2025). [PMID: 40209709](https://pubmed.ncbi.nlm.nih.gov/40209709/). *Current biology : CB*. [Basic Science / Preclinical]
Daşar T (2025). [PMID: 39911177](https://pubmed.ncbi.nlm.nih.gov/39911177/). *Molecular syndromology*. [Case Report / Case Series]
Voigt B (2024). [PMID: 39211248](https://pubmed.ncbi.nlm.nih.gov/39211248/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Müller SM (2024). [PMID: 38791291](https://pubmed.ncbi.nlm.nih.gov/38791291/). *International journal of molecular sciences*. [Review / Meta-Analysis]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 6:53 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Arms and legs | 4 | Short foot, Disproportionate short-limb short stature, Short phalanx of finger |
Muscles | 3 | Low muscle tone (hypotonia), Generalized hypotonia, Renal phosphate wasting |
Growth and development | 2 | Severe short stature, Disproportionate short-limb short stature |
Head and neck | 2 | Relative macrocephaly, Macrocephaly |
Lungs and breathing | 2 | Difficulty breathing (respiratory insufficiency), Recurrent respiratory infections |
Blood and immune system | 2 | Recurrent respiratory infections, Enlarged spleen (splenomegaly) |
Digestive system | 2 | Enlarged spleen (splenomegaly), Enlarged liver (hepatomegaly) |
Kidneys and urinary system | 1 | Renal phosphate wasting |
Skin | 1 | Soft, doughy skin |
Brain and nerves | 1 | Depressed nasal bridge |
Age of onset: before birth.
INPPL1-related opsismodysplasia is characterized by prenatal-onset short stature, short limbs, small hands and feet, narrow thorax, dysmorphic facial features (including relative macrocephaly, prominent forehead, midface retrusion, depressed nasal bridge, short nose, anteverted nares, and relatively long philtrum), delayed epiphyseal mineralization, metaphyseal cupping, and platyspondyly. To date, 35 individuals have been identified with biallelic pathogenic variants in INPPL1 [, , , , , , , ]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. INPPL1-Related Opsismodysplasia: Frequency of Select Features
Feature | % of Persons w/Feature | Comment |
|---|---|---|
Short stature | 10/10 | — |
Short long bones | 15/19 | Long bones are often bowed. |
Short hands/feet | 18/20 | — |
Delayed epiphyseal mineralization | 18/20 | — |
Metaphyseal cupping | 17/20 | — |
Platyspondyly | 13/18 | — |
Small/narrow thorax | 7/19 | — |
Renal phosphate wasting/ hypophosphatemia | 7/10 | — |
Respiratory issues | 15/20 | Prenatal. Reported prenatal ultrasound findings reflect the underlying skeletal differences, including short limbs, short long bones, short hands and feet, narrow thorax, bell-shaped thorax, platyspondyly, and decreased bone echogenicity. |
Source: GeneReviews — "INPPL1-Related Opsismodysplasia"
Narrow thorax
Small hands and feet
Respiratory insufficiency
Laboratory findings
Severe renal phosphate wasting
Hypophosphatemia
Imaging findings
Source: GeneReviews — "INPPL1-Related Opsismodysplasia"
Biallelic pathogenic variants in INPPL1 were identified in approximately 60% of individuals with opsismodysplasia in one cohort . The genetic etiology has not been identified in some individuals with clinical findings consistent with opsismodysplasia . Table 3. Genes of Interest in the Differential Diagnosis of INPPL1-Related Opsismodysplasia
Gene(s) | Disorder | MOI | Features of Disorder |
|---|---|---|---|
COL1A1/2 osteogenesis imperfecta | AD | Short stature, short limbs, osteopenia, fractures, limb malalignment, platyspondyly, respiratory insufficiency | Wormian bones lack of other skeletal findings assoc w/INPPL1-related opsismodysplasia; No renal phosphate wasting/ hypophosphatemia |
COL2A1 | Type II collagen disorders (severe to moderately severe phenotypes) | AD1 | May be lethal in perinatal period; Short stature, short limbs, platyspondyly, cervical instability, epiphyseal delay, metaphyseal cupping |
Osteoglophonic dysplasia | AD | Short stature, short limbs, brachydactyly, metatarsal irregularity, lower extremity bowing, platyspondyly; Renal phosphate wasting/ hypophosphatemia | Craniosynostosis, non-ossifying bone lesions, unerupted/retained teeth FGFR3 |
Thanatophoric dysplasia | AD | Often lethal in perinatal period; Short stature, short limbs, brachydactyly, platyspondyly, narrow chest, relative macrocephaly | Cloverleaf skull, foramen magnum narrowing, severely bowed femurs, trident hand; No renal phosphate wasting/ hypophosphatemia |
FAM111A | Osteocraniostenosis (See FAM111A-Related Skeletal Dysplasias.) | AD | Often lethal in perinatal period; Short stature, short limbs, metaphyseal flaring, brachydactyly, bone fractures |
GPX4 | Severe spondylometaphyseal dysplasia (Sedhaghatian type), GPX4-related (OMIM 250220) | AR | Short stature, delayed ossification/ epiphyseal delay, brachydactyly, small hands/feet, short long bones, metaphyseal cupping, platyspondyly, narrow chest |
PAM16 | Spondylometaphyseal dysplasia, PAM16-related (OMIM 613320) | AR | Short stature, delayed ossification, short long bones, metaphyseal cupping, platyspondyly, small chest |
Source: GeneReviews — "INPPL1-Related Opsismodysplasia"
Genetic testing for INPPL1 is available. Testing is considered confirmatory for diagnosis.
System/Concern | Evaluation | Comment |
|---|---|---|
Cardiac | Echocardiogram | — |
Renal | Renal ultrasound | ENT |
Genetic counseling | By genetics professionals1 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of INPPL1-related opsismodysplasia to facilitate medical personal decision making Family support resources |
Source: GeneReviews — "INPPL1-Related Opsismodysplasia"
View trials for opsismodysplasia
Evaluation |
|---|
Frequency |
|---|
Skeletal manifestations | Flexion-extension cervical spine MRI if there is instability, risk of cervical cord compression, or limited radiograph interpretation | Every 3-6 mos until cervical instability can be excluded; Then every 2-3 years, preoperatively, when indicated |
Scoliosis | Clinical exam w/radiographs when indicated | Every 6-12 mos or when indicated based on progression severity Endocrine |
Feeding | Swallowing eval | When indicated to evaluate risk of aspiration Development; Rehab medicine, PT, OT consultations when indicated to evaluate function need for adaptive devices to support activities of daily living mobility |
Cardiac | Clinical cardiac exam | Per cardiologist |
ENT/Mouth | Audiology eval | Annually or more frequently as indicated Clinical exam; ENT orthodontic follow up |
Source: GeneReviews — "INPPL1-Related Opsismodysplasia"
Phenotype severity distribution: 13 always present features, 10 very common features, 9 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).